Anxiety

5th October 20196th October 2019Immo Weichert

Cognitive behavioural therapy delivered by respiratory nurses is clinically effective and cost-effective for patients with chronic obstructive pulmonary disease and symptoms of anxiety

This is a randomised controlled trial that was published in 2018. [1] A total of 236 patients with a diagnosis of mild to very severe COPD took part in the trial. Each patient was screened for anxiety using the HADS-Anxiety Subscale. This is a questionnaire that asks patients about their feelings of anxiety and depression…

2nd October 20192nd October 2019Immo Weichert

Anxiety and depression in renal disease

This is a narrative review that was published in 2018. [1] The authors there describe the evidence surrounding psychiatric comorbidity in patients with kidney disease, including the effect on progression and mortality. 1 Goh ZS, Griva K. Anxiety and depression in patients with end-stage renal disease: Impact and management challenges – A narrative review.…

1st October 20191st October 2019Immo Weichert

Prevalence of anxiety in people with epilepsy

This is a study from 2017 that used data from the Neurological Disease and Depression Study. [1] Of the total sample (n = 250 patients), nearly 40.0% of participants had anxiety according to the Hospital Anxiety and Depression Scale. The most prevalent symptom of anxiety was “worrying thoughts” (35.6%). After adjustment for age and sex,…

1st October 20192nd October 2019Immo Weichert

The prevalence of anxiety in patients with COPD

This is a systematic review that was published in 2013. [1] 10 studies met the inclusion criteria for review. The studies had small to modest sample sizes and included mainly male COPD patients (71% male). The prevalence of clinical anxiety ranged from 10–55% among in-patients and 13–46% among out-patients with COPD. The authors further describe…